Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Merit Medical Systems stock

Own Merit Medical Systems stock in just a few minutes.

Posted

Fact checked

Merit Medical Systems, Inc is a medical instruments & supplies business based in the US. Merit Medical Systems shares (MMSI) are listed on the NASDAQ and all prices are listed in US Dollars. Merit Medical Systems employs 6,000 staff and has a trailing 12-month revenue of around USD$962.9 million.

How to buy shares in Merit Medical Systems

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Merit Medical Systems. Find the stock by name or ticker symbol: MMSI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Merit Medical Systems reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Merit Medical Systems, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Merit Medical Systems. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Merit Medical Systems share price

Use our graph to track the performance of MMSI stocks over time.

Merit Medical Systems shares at a glance

Information last updated 2020-10-21.
52-week range USD$19.5 - USD$50.38
50-day moving average USD$45.5409
200-day moving average USD$43.3361
Wall St. target price USD$51.38
PE ratio 379.2
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.332

Buy Merit Medical Systems shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Merit Medical Systems stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Merit Medical Systems under- or over-valued?

Valuing Merit Medical Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merit Medical Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Merit Medical Systems's P/E ratio

Merit Medical Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 379x. In other words, Merit Medical Systems shares trade at around 379x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Merit Medical Systems's PEG ratio

Merit Medical Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4764. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Merit Medical Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Merit Medical Systems's EBITDA

Merit Medical Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$136.2 million.

The EBITDA is a measure of a Merit Medical Systems's overall financial performance and is widely used to measure a its profitability.

Merit Medical Systems financials

Revenue TTM USD$962.9 million
Operating margin TTM 4.37%
Gross profit TTM USD$432.4 million
Return on assets TTM 1.53%
Return on equity TTM -3.17%
Profit margin -3.1%
Book value $16.742
Market capitalisation USD$2.6 billion

TTM: trailing 12 months

Shorting Merit Medical Systems shares

There are currently 3.5 million Merit Medical Systems shares held short by investors – that's known as Merit Medical Systems's "short interest". This figure is 10.3% down from 3.9 million last month.

There are a few different ways that this level of interest in shorting Merit Medical Systems shares can be evaluated.

Merit Medical Systems's "short interest ratio" (SIR)

Merit Medical Systems's "short interest ratio" (SIR) is the quantity of Merit Medical Systems shares currently shorted divided by the average quantity of Merit Medical Systems shares traded daily (recently around 488348). Merit Medical Systems's SIR currently stands at 7.25. In other words for every 100,000 Merit Medical Systems shares traded daily on the market, roughly 7250 shares are currently held short.

However Merit Medical Systems's short interest can also be evaluated against the total number of Merit Medical Systems shares, or, against the total number of tradable Merit Medical Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Merit Medical Systems's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Merit Medical Systems shares in existence, roughly 60 shares are currently held short) or 0.089% of the tradable shares (for every 100,000 tradable Merit Medical Systems shares, roughly 89 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Merit Medical Systems.

Find out more about how you can short Merit Medical Systems stock.

Merit Medical Systems share dividends

We're not expecting Merit Medical Systems to pay a dividend over the next 12 months.

Have Merit Medical Systems's shares ever split?

Merit Medical Systems's shares were split on a 5:4 basis on 6 May 2011. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Merit Medical Systems shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for Merit Medical Systems shares which in turn could have impacted Merit Medical Systems's share price.

Merit Medical Systems share price volatility

Over the last 12 months, Merit Medical Systems's shares have ranged in value from as little as $19.5 up to $50.38. A popular way to gauge a stock's volatility is its "beta".

MMSI.US volatility(beta: 1.1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Merit Medical Systems's is 1.0987. This would suggest that Merit Medical Systems's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Merit Medical Systems overview

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, interventional fluid management, pressure monitoring, and cardiac rhythm management, as well as thermodilution and pulmonary artery catheters and electrophysiology to treat various heart conditions. It also offers cardiovascular and critical care products to treat patients with life-threatening diseases, and protect healthcare providers from exposure to bloodborne pathogens. In addition, it provides interventional oncology and spine products to treat vertebral compression fractures, metastatic spinal tumors, liver cancer, uterine fibroids, benign prostatic hyperplasia, vertebral compression fractures, and arteriovenous malformations and hemostatic embolization, as well as breast cancer localization and guidance products for the treatment of breast cancer. Further, it offers non-vascular stents to treat pulmonary and gastrointestinal diseases; dilation balloons to endoscopically dilate strictures; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; microelectromechanical system sensor components; ConvertX nephroureteral stent system; and Fibrovein, a detergent-based sclerosant. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was founded in 1987 and is headquartered in South Jordan, Utah.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site